Haemonetics (NYSE:HAE) Now Covered by Analysts at Robert W. Baird
Robert W. Baird started coverage on shares of Haemonetics (NYSE:HAE – Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $87.00 price target on the medical instruments supplier’s stock. Several other equities research analysts have also recently issued reports on the stock. […]
Robert W. Baird started coverage on shares of Haemonetics (NYSE:HAE – Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $87.00 price target on the medical instruments supplier’s stock. Several other equities research analysts have also recently issued reports on the stock. […]
